FDA expands use of AstraZeneca/Merck ovarian cancer drug
(Reuters) - The U.S. Food and Drug Administration on Thursday expanded the use of Lynparza, sold by AstraZeneca Plc (AZN.L) and Merck & Co Inc (MRK.N), to include ongoing treatment of patients with recurrent ...


